667P Impact of pretreatment neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) on overall survival (OS) in patients (p) with metastatic castration-sensitive prostate cancer (mCSPC) treated with docetaxel (D) plus androgen-deprivation therapy (ADT)

Autor: Notario, L., Piulats, J.M., Sala, N., Ferrandiz, U., González, A., Etxániz, O., Heras, L., Buisan, O., Del Carpio, L., Álvarez, A., Boladeras, A., Roselló, A., Barretina, P., Fina, C., Pardo, J.C., Suárez, J.M., Comet, J., Garcia del Muro, X., Esteve, A., Font, A.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S537-S537
Databáze: ScienceDirect